Header Logo

Connection

TETSUO ASHIZAWA to Spinocerebellar Ataxias

Back to Details
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Spinocerebellar Ataxias.
TETSUO ASHIZAWA
Connection Strength
18.429
Spinocerebellar Ataxias
  1. Extended haplotype with rs41524547-G defines the ancestral origin of SCA10. Hum Mol Genet. 2024 09 03; 33(18):1567-1574.
    View in: PubMed
    Score: 0.726
  2. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3. Neurology. 2023 04 25; 100(17):e1836-e1848.
    View in: PubMed
    Score: 0.652
  3. Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions. Cells. 2022 05 06; 11(9).
    View in: PubMed
    Score: 0.618
  4. Comparing loss of balance and functional capacity among patients with SCA2, SCA3 and SCA10. Clin Neurol Neurosurg. 2022 03; 214:107150.
    View in: PubMed
    Score: 0.607
  5. Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients. Parkinsonism Relat Disord. 2020 09; 78:73-78.
    View in: PubMed
    Score: 0.546
  6. Cancer frequency in patients with spinocerebellar ataxia type 10. Parkinsonism Relat Disord. 2020 07; 76:1-2.
    View in: PubMed
    Score: 0.540
  7. Cerebellar and thalamic degeneration in spinocerebellar ataxia type 10. Parkinsonism Relat Disord. 2020 07; 76:76-77.
    View in: PubMed
    Score: 0.533
  8. Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5):849-854.
    View in: PubMed
    Score: 0.516
  9. Spinocerebellar ataxias in Southern Brazil: Genotypic and phenotypic evaluation of 213 families. Clin Neurol Neurosurg. 2019 Sep; 184:105427.
    View in: PubMed
    Score: 0.508
  10. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol. 2018 10; 14(10):590-605.
    View in: PubMed
    Score: 0.482
  11. A crystal ball for survival for spinocerebellar ataxias? Lancet Neurol. 2018 04; 17(4):292-294.
    View in: PubMed
    Score: 0.464
  12. Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions. PLoS One. 2017; 12(4):e0175958.
    View in: PubMed
    Score: 0.436
  13. SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS One. 2015; 10(8):e0135906.
    View in: PubMed
    Score: 0.388
  14. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013 Nov 13; 8:177.
    View in: PubMed
    Score: 0.343
  15. Spinocerebellar ataxia type 10: from Amerindians to Latin Americans. Curr Neurol Neurosci Rep. 2013 Nov; 13(11):393.
    View in: PubMed
    Score: 0.343
  16. Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1409-11.
    View in: PubMed
    Score: 0.335
  17. Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci. 2013 Oct; 51(2):237-48.
    View in: PubMed
    Score: 0.322
  18. GGCCTG repeats put a hex on Purkinje cells and motor neurons in SCA36. Neurology. 2012 Jul 24; 79(4):302-3.
    View in: PubMed
    Score: 0.312
  19. Spinocerebellar ataxia type 10. Handb Clin Neurol. 2012; 103:507-19.
    View in: PubMed
    Score: 0.302
  20. Ethnic origin and extrapyramidal signs in an Argentinean spinocerebellar ataxia type 10 family. Neurology. 2007 Jul 10; 69(2):216-8.
    View in: PubMed
    Score: 0.221
  21. The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10. Neurology. 2006 Aug 22; 67(4):607-13.
    View in: PubMed
    Score: 0.208
  22. Prevalence, Severity, and Progression of Cerebellar Cognitive-Affective Syndrome in Patients With Spinocerebellar Ataxias. Neurology. 2025 Sep 09; 105(5):e213980.
    View in: PubMed
    Score: 0.194
  23. Fixel-Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia. Ann Clin Transl Neurol. 2025 Sep; 12(9):1846-1857.
    View in: PubMed
    Score: 0.193
  24. Suicidal Ideation in Spinocerebellar Ataxia. J Neuropsychiatry Clin Neurosci. 2026; 38(1):38-44.
    View in: PubMed
    Score: 0.190
  25. The impact of interrupted ATXN10 expansions on clinical findings of spinocerebellar ataxia type 10. J Neurol. 2025 Mar 11; 272(4):261.
    View in: PubMed
    Score: 0.188
  26. Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
    View in: PubMed
    Score: 0.188
  27. ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. Cerebellum. 2025 Jan 16; 24(2):33.
    View in: PubMed
    Score: 0.186
  28. Recent progress in spinocerebellar ataxia type-10 (SCA10). Cerebellum. 2005; 4(1):37-42.
    View in: PubMed
    Score: 0.186
  29. Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six?Months in Early Spinocerebellar Ataxia. Mov Disord. 2024 Oct; 39(10):1856-1867.
    View in: PubMed
    Score: 0.180
  30. SARA captures disparate progression and responsiveness in spinocerebellar ataxias. J Neurol. 2024 Jul; 271(7):3743-3753.
    View in: PubMed
    Score: 0.178
  31. Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet. 2004 Jun; 74(6):1216-24.
    View in: PubMed
    Score: 0.177
  32. Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 May; 11(5):496-503.
    View in: PubMed
    Score: 0.175
  33. The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias. Cerebellum. 2024 Aug; 23(4):1411-1425.
    View in: PubMed
    Score: 0.173
  34. SCAview: an Intuitive Visual Approach to the Integrative Analysis of Clinical Data in Spinocerebellar Ataxias. Cerebellum. 2024 Jun; 23(3):887-895.
    View in: PubMed
    Score: 0.164
  35. SCA10 and ATTCT repeat expansion: clinical features and molecular aspects. Cytogenet Genome Res. 2003; 100(1-4):184-8.
    View in: PubMed
    Score: 0.162
  36. Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3. Ann Neurol. 2023 04; 93(4):686-701.
    View in: PubMed
    Score: 0.162
  37. The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications. Cerebellum. 2023 Oct; 22(5):790-809.
    View in: PubMed
    Score: 0.157
  38. Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10. Arch Neurol. 2002 Aug; 59(8):1285-90.
    View in: PubMed
    Score: 0.157
  39. Spinocerebellar ataxia type 10 is rare in populations other than Mexicans. Neurology. 2002 Mar 26; 58(6):983-4.
    View in: PubMed
    Score: 0.153
  40. Polymerase chain reaction amplification of expanded ATTCT repeat in spinocerebellar ataxia type 10. Ann Neurol. 2002 Feb; 51(2):271-2.
    View in: PubMed
    Score: 0.152
  41. Spinocerebellar ataxia type 10: a disease caused by a large ATTCT repeat expansion. Adv Exp Med Biol. 2002; 516:79-97.
    View in: PubMed
    Score: 0.151
  42. [Spinocerebellar ataxia type 10 (SCA10): a disease caused by a novel pentanucleotide repeat expansion]. Rinsho Shinkeigaku. 2001 Dec; 41(12):1120-2.
    View in: PubMed
    Score: 0.150
  43. Reply to: "Cognitive Impairments in Spinocerebellar Ataxia Type 10 and Their Relation to Cortical Thickness". Mov Disord. 2021 12; 36(12):2977.
    View in: PubMed
    Score: 0.150
  44. Blood Neurofilament Light Chain in Genetic Ataxia: A Meta-Analysis. Mov Disord. 2022 01; 37(1):171-181.
    View in: PubMed
    Score: 0.148
  45. DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases. Neurotherapeutics. 2021 07; 18(3):1710-1728.
    View in: PubMed
    Score: 0.145
  46. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol. 2001 Feb; 58(2):191-5.
    View in: PubMed
    Score: 0.142
  47. Balance and physical functioning in Spinocerebellar ataxias 3 and 10. Acta Neurol Scand. 2021 Apr; 143(4):458-463.
    View in: PubMed
    Score: 0.140
  48. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
    View in: PubMed
    Score: 0.138
  49. Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean. Cerebellum. 2020 Jun; 19(3):446-458.
    View in: PubMed
    Score: 0.135
  50. Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6. J Neurol Sci. 2020 Aug 15; 415:116878.
    View in: PubMed
    Score: 0.134
  51. Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS One. 2020; 15(3):e0228789.
    View in: PubMed
    Score: 0.133
  52. Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet. 1999 Dec; 8(13):2473-8.
    View in: PubMed
    Score: 0.131
  53. Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum. 2019 Jun; 18(3):519-526.
    View in: PubMed
    Score: 0.126
  54. Olfactory Function in SCA10. Cerebellum. 2019 Feb; 18(1):85-90.
    View in: PubMed
    Score: 0.123
  55. Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells. Cerebellum. 2019 Feb; 18(1):99-108.
    View in: PubMed
    Score: 0.123
  56. Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group. Nutr Neurosci. 2020 Jan; 23(1):49-54.
    View in: PubMed
    Score: 0.117
  57. Sleep disorders in spinocerebellar ataxia type 10. J Sleep Res. 2018 10; 27(5):e12688.
    View in: PubMed
    Score: 0.116
  58. Spinocerebellar ataxias type 3 and 10: Onset and progression of ataxia during pregnancy and puerperium. Parkinsonism Relat Disord. 2018 07; 52:119-120.
    View in: PubMed
    Score: 0.116
  59. Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10. Cerebellum. 2017 Dec; 16(5-6):938-944.
    View in: PubMed
    Score: 0.114
  60. C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias. Mov Disord. 2018 03; 33(3):497-498.
    View in: PubMed
    Score: 0.114
  61. Dystonia and ataxia progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2017 Dec; 45:75-80.
    View in: PubMed
    Score: 0.113
  62. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2017; 7:492.
    View in: PubMed
    Score: 0.113
  63. A Comparative Optical Coherence Tomography Study of Spinocerebellar Ataxia Types 3 and 10. Cerebellum. 2017 08; 16(4):797-801.
    View in: PubMed
    Score: 0.111
  64. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias. Cerebellum. 2017 06; 16(3):615-622.
    View in: PubMed
    Score: 0.110
  65. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis. Ann Neurol. 2016 10; 80(4):600-15.
    View in: PubMed
    Score: 0.105
  66. Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6. Brain Struct Funct. 2017 03; 222(2):1039-1052.
    View in: PubMed
    Score: 0.103
  67. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016 Jan; 22:87-92.
    View in: PubMed
    Score: 0.099
  68. Spinocerebellar ataxia type 10 in the South of Brazil: the Amerindian-Belgian connection. Arq Neuropsiquiatr. 2015 Aug; 73(8):725-7.
    View in: PubMed
    Score: 0.097
  69. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015 Mar; 35(1):16-21.
    View in: PubMed
    Score: 0.094
  70. Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand. 2015 Aug; 132(2):139-42.
    View in: PubMed
    Score: 0.093
  71. Coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015 Feb; 30(2):214-20.
    View in: PubMed
    Score: 0.092
  72. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014 Sep; 137(Pt 9):2444-55.
    View in: PubMed
    Score: 0.090
  73. Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease. J Neurol. 2014 Sep; 261(9):1691-4.
    View in: PubMed
    Score: 0.089
  74. Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum. 2014 Apr; 13(2):269-302.
    View in: PubMed
    Score: 0.088
  75. Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures. Neurogenetics. 2014 Mar; 15(1):59-64.
    View in: PubMed
    Score: 0.086
  76. Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS One. 2013; 8(11):e81342.
    View in: PubMed
    Score: 0.086
  77. Paradoxical effects of repeat interruptions on spinocerebellar ataxia type 10 expansions and repeat instability. Eur J Hum Genet. 2013 Nov; 21(11):1272-6.
    View in: PubMed
    Score: 0.082
  78. Acute onset of cerebellar ataxia in a spinocerebellar ataxia type 10 patient after use of steroids. Arq Neuropsiquiatr. 2013 Jan; 71(1):66.
    View in: PubMed
    Score: 0.081
  79. Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13(R420H). Neurology. 2012 Sep 11; 79(11):1181-2.
    View in: PubMed
    Score: 0.079
  80. Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families. Clinics (Sao Paulo). 2012; 67(5):443-9.
    View in: PubMed
    Score: 0.075
  81. Objective home-based gait assessment in spinocerebellar ataxia. J Neurol Sci. 2012 Feb 15; 313(1-2):95-8.
    View in: PubMed
    Score: 0.074
  82. Spinocerebellar ataxia type 10: disproportionate cerebellar symptoms among at-risk subjects induced by small amounts of alcohol. Arq Neuropsiquiatr. 2011 Oct; 69(5):841.
    View in: PubMed
    Score: 0.074
  83. Spinocerebellar ataxia type 10 - A review. Parkinsonism Relat Disord. 2011 Nov; 17(9):655-61.
    View in: PubMed
    Score: 0.072
  84. New gene of spinocerebellar ataxia. Brain. 2011 Jul; 134(Pt 7):e179.
    View in: PubMed
    Score: 0.071
  85. Symptom onset of spinocerebellar ataxia type 10 in pregnancy and puerperium. J Clin Neurosci. 2011 Mar; 18(3):437-8.
    View in: PubMed
    Score: 0.071
  86. Spinocerebellar ataxia type 10: Frequency of epilepsy in a large sample of Brazilian patients. Mov Disord. 2010 Dec 15; 25(16):2875-8.
    View in: PubMed
    Score: 0.070
  87. The history of spinocerebellar ataxia type 10 in Brazil: travels of a gene. Arq Neuropsiquiatr. 2007 Dec; 65(4A):965-8.
    View in: PubMed
    Score: 0.057
  88. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet. 2008 Feb; 16(2):215-22.
    View in: PubMed
    Score: 0.057
  89. Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17. Ann Neurol. 2007 Jun; 61(6):607-10.
    View in: PubMed
    Score: 0.055
  90. Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Mov Disord. 2007 May 15; 22(7):1050-3.
    View in: PubMed
    Score: 0.055
  91. Reduced penetrance in a Brazilian family with spinocerebellar ataxia type 10. Arch Neurol. 2007 Apr; 64(4):591-4.
    View in: PubMed
    Score: 0.054
  92. Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10. Neurology. 2006 May 23; 66(10):1602-4.
    View in: PubMed
    Score: 0.051
  93. Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier? Am J Hum Genet. 2006 Jan; 78(1):125-9.
    View in: PubMed
    Score: 0.049
  94. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology. 2004 Oct 26; 63(8):1509-12.
    View in: PubMed
    Score: 0.046
  95. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet. 2004 Jul; 75(1):3-16.
    View in: PubMed
    Score: 0.044
  96. Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. J Mol Diagn. 2004 May; 6(2):96-100.
    View in: PubMed
    Score: 0.044
  97. Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeats. J Mol Biol. 2003 Feb 28; 326(4):1095-111.
    View in: PubMed
    Score: 0.041
  98. Spinocerebellar ataxia type 10 in the French population. Ann Neurol. 2002 Mar; 51(3):408-9.
    View in: PubMed
    Score: 0.038
  99. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001 Aug; 50(2):234-9.
    View in: PubMed
    Score: 0.037
  100. An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia. Neurology. 2000 Jan 25; 54(2):491-3.
    View in: PubMed
    Score: 0.033
  101. Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13. Cerebellum. 2013 Dec; 12(6):932-6.
    View in: PubMed
    Score: 0.022
  102. Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One. 2013; 8(10):e76749.
    View in: PubMed
    Score: 0.021
  103. Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. Neurobiol Aging. 2013 Oct; 34(10):2442.e11-7.
    View in: PubMed
    Score: 0.021
  104. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012 Oct; 83(10):970-4.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.